• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I 类 HLA 等位基因预测的具核梭杆菌 Fap2 蛋白的抗原覆盖范围与结直肠癌的发生相关。

Class I HLA Allele Predicted Restricted Antigenic Coverages for Fap2 Protein of Fusobacterium Nucleatum Are Associated with Colorectal Cancer Incidence.

机构信息

Laboratory of Agro-Industrial and Medical Biotechnology, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, B.P. 523, Béni Mellal, Morocco.

出版信息

Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3629-3636. doi: 10.31557/APJCP.2023.24.10.3629.

DOI:10.31557/APJCP.2023.24.10.3629
PMID:37898872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10770689/
Abstract

OBJECTIVE

This study investigates the association between HLA-A and -B allele diversity, Fusobacterium nucleatum Fap2 protein-derived antigenic coverage, and colorectal cancer (CRC) epidemiology across diverse populations.

METHODS

We examined 75 HLA-I alleles and explored 698 potential HLA-A and B-restricted Fap2-derived antigens, assessing how 21 countries may respond to these peptides based on their HLA-I distribution frequencies. Additionally, we correlated in-silico predicted Fap2 population coverage with CRC epidemiology. CRC incidence and mortality data were obtained from the Global Cancer Observatory, and HLA-A and HLA-B allele frequencies from the Allele Frequency Net Database. Binding predictions for Fap2 antigens were performed using netMHCpan4, with stringent selection criteria applied to identify relevant peptides. Population coverage was calculated using the IEDB population coverage tool, and data analysis conducted using the R programming language.

RESULTS

Clustering of HLA-A and -B allele frequencies partially differentiated countries with lower CRC incidence from others. Distinct patterns of Fap2 protein coverage were observed among different populations. interestingly, we found a significant inverse correlation between CRC incidence (p = 0.0037, R = -0.6) and predicted Fap2 antigen coverage, as well as CRC mortality (p = 0.013, R = -0.53). Furthermore, we identified a specific set of Fap2-derived peptides that bind to HLA supertypes, providing a global coverage of 99.04%.

CONCLUSION

Our population-based study is the first to demonstrate that higher Fap2 coverage is associated with lower CRC incidence, underscoring the potential significance of Fap2-specific CD8+ T cell responses in CRC tumorigenesis.

摘要

目的

本研究旨在调查人类白细胞抗原(HLA)-A 和 -B 等位基因多样性、具核梭杆菌 Fap2 蛋白衍生抗原的抗原覆盖范围,以及它们与不同人群结直肠癌(CRC)流行病学之间的关联。

方法

我们检测了 75 个 HLA-I 等位基因,并探索了 698 个可能的 HLA-A 和 B 限制性 Fap2 衍生抗原,评估了基于 HLA-I 分布频率,21 个国家对这些肽的反应情况。此外,我们还将 Fap2 人群覆盖度的计算机预测与 CRC 流行病学进行了相关性分析。CRC 的发病率和死亡率数据来自全球癌症观测站,HLA-A 和 HLA-B 等位基因频率来自 Allele Frequency Net 数据库。使用 netMHCpan4 进行 Fap2 抗原的结合预测,采用严格的选择标准来鉴定相关肽。使用 IEDB 人群覆盖工具计算人群覆盖度,并使用 R 编程语言进行数据分析。

结果

HLA-A 和 -B 等位基因频率的聚类部分区分了 CRC 发病率较低的国家和其他国家。不同人群中观察到 Fap2 蛋白覆盖范围存在不同的模式。有趣的是,我们发现 CRC 发病率(p = 0.0037,R = -0.6)和预测的 Fap2 抗原覆盖度之间存在显著的负相关,以及 CRC 死亡率(p = 0.013,R = -0.53)。此外,我们鉴定出一组与 HLA 超型结合的特定 Fap2 衍生肽,提供了 99.04%的全球覆盖度。

结论

本基于人群的研究首次表明,较高的 Fap2 覆盖度与较低的 CRC 发病率相关,突出了 Fap2 特异性 CD8+ T 细胞反应在 CRC 肿瘤发生中的潜在意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/10770689/8d9eaa8fc40d/APJCP-24-3629-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/10770689/c27c10ff9a99/APJCP-24-3629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/10770689/7816831b0264/APJCP-24-3629-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/10770689/095775488035/APJCP-24-3629-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/10770689/8d9eaa8fc40d/APJCP-24-3629-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/10770689/c27c10ff9a99/APJCP-24-3629-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/10770689/7816831b0264/APJCP-24-3629-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/10770689/095775488035/APJCP-24-3629-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2ed8/10770689/8d9eaa8fc40d/APJCP-24-3629-g004.jpg

相似文献

1
Class I HLA Allele Predicted Restricted Antigenic Coverages for Fap2 Protein of Fusobacterium Nucleatum Are Associated with Colorectal Cancer Incidence.I 类 HLA 等位基因预测的具核梭杆菌 Fap2 蛋白的抗原覆盖范围与结直肠癌的发生相关。
Asian Pac J Cancer Prev. 2023 Oct 1;24(10):3629-3636. doi: 10.31557/APJCP.2023.24.10.3629.
2
Immunogenicity of a Fap2 peptide mimotope of and its potential use in the diagnosis of colorectal cancer.一种[具体名称未给出]的Fap2肽模拟表位的免疫原性及其在结直肠癌诊断中的潜在应用。
Infect Agent Cancer. 2018 Apr 2;13:11. doi: 10.1186/s13027-018-0184-7. eCollection 2018.
3
Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.Fap2通过与肿瘤表达的半乳糖- N -乙酰半乳糖胺结合介导具核梭杆菌在结直肠癌中的富集。
Cell Host Microbe. 2016 Aug 10;20(2):215-25. doi: 10.1016/j.chom.2016.07.006.
4
host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration.宿主细胞结合和入侵诱导 IL-8 和 CXCL1 的分泌,从而促进结直肠癌细胞的迁移。
Sci Signal. 2020 Jul 21;13(641):eaba9157. doi: 10.1126/scisignal.aba9157.
5
Cell Surface Fibroblast Activation Protein-2 (Fap2) of as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics Approach.人结直肠癌治疗干预候选疫苗——细胞表面成纤维细胞激活蛋白-2(Fap2):一种免疫信息学方法
Vaccines (Basel). 2023 Feb 23;11(3):525. doi: 10.3390/vaccines11030525.
6
Targeting Programmed Fap2 for Colorectal Cancer Therapy.靶向程序性Fap2用于结直肠癌治疗
Cancers (Basel). 2019 Oct 18;11(10):1592. doi: 10.3390/cancers11101592.
7
Class I HLA Allele Predicted Restricted Antigenic Coverages for Spike and Nucleocapsid Proteins Are Associated With Deaths Related to COVID-19.I 类 HLA 等位基因预测的刺突蛋白和核衣壳蛋白的受限抗原覆盖范围与 COVID-19 相关死亡有关。
Front Immunol. 2020 Dec 16;11:565730. doi: 10.3389/fimmu.2020.565730. eCollection 2020.
8
Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.具核梭杆菌与结直肠癌:机制概述。
J Cell Physiol. 2019 Mar;234(3):2337-2344. doi: 10.1002/jcp.27250. Epub 2018 Sep 7.
9
Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression.具核梭杆菌定植促进乳腺癌的生长和转移进展。
Nat Commun. 2020 Jun 26;11(1):3259. doi: 10.1038/s41467-020-16967-2.
10
In silico analysis of HLA-1 and HLA-2 recognition of a designed recombinant human papillomavirus vaccine based on L1 protein HPV subtype 45.基于人乳头瘤病毒45型L1蛋白的设计重组人乳头瘤病毒疫苗的HLA-1和HLA-2识别的计算机模拟分析
J Genet Eng Biotechnol. 2023 Dec 13;21(1):167. doi: 10.1186/s43141-023-00593-8.

引用本文的文献

1
Anaerobic gut bacteria and their potential role in the initiation, exacerbation, and development of human colorectal cancer: a narrative review.厌氧肠道细菌及其在人类结直肠癌的起始、恶化和发展中的潜在作用:一篇叙述性综述。
Front Cell Infect Microbiol. 2025 Jul 25;15:1559001. doi: 10.3389/fcimb.2025.1559001. eCollection 2025.
2
HLA-B*58 and HLA-B*27 Play a Role in the Development of Acute Leukemia: A Case Control Study.HLA-B*58 和 HLA-B*27 与急性白血病的发生有关:一项病例对照研究。
Asian Pac J Cancer Prev. 2024 Jan 1;25(1):169-173. doi: 10.31557/APJCP.2024.25.1.169.

本文引用的文献

1
Cell Surface Fibroblast Activation Protein-2 (Fap2) of as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics Approach.人结直肠癌治疗干预候选疫苗——细胞表面成纤维细胞激活蛋白-2(Fap2):一种免疫信息学方法
Vaccines (Basel). 2023 Feb 23;11(3):525. doi: 10.3390/vaccines11030525.
2
Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer.具核梭杆菌,结直肠癌的关键致病因子和微生物生物标志物。
Trends Microbiol. 2023 Feb;31(2):159-172. doi: 10.1016/j.tim.2022.08.010. Epub 2022 Sep 1.
3
Cancer statistics, 2022.
癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
4
Association of with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment.与结直肠癌微环境中特定 T 细胞亚群的关联。
Clin Cancer Res. 2021 May 15;27(10):2816-2826. doi: 10.1158/1078-0432.CCR-20-4009. Epub 2021 Feb 25.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives.基于计算机的 SARS-CoV-2 细胞表位预测:进展与展望。
Adv Drug Deliv Rev. 2021 Apr;171:29-47. doi: 10.1016/j.addr.2021.01.007. Epub 2021 Jan 17.
7
targets lncRNA ENO1-IT1 to promote glycolysis and oncogenesis in colorectal cancer.靶向 lncRNA ENO1-IT1 促进结直肠癌的糖酵解和肿瘤发生。
Gut. 2021 Nov;70(11):2123-2137. doi: 10.1136/gutjnl-2020-322780. Epub 2020 Dec 14.
8
T Cell Immunity to Bacterial Pathogens: Mechanisms of Immune Control and Bacterial Evasion.T 细胞对细菌病原体的免疫:免疫控制和细菌逃避的机制。
Int J Mol Sci. 2020 Aug 26;21(17):6144. doi: 10.3390/ijms21176144.
9
host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration.宿主细胞结合和入侵诱导 IL-8 和 CXCL1 的分泌,从而促进结直肠癌细胞的迁移。
Sci Signal. 2020 Jul 21;13(641):eaba9157. doi: 10.1126/scisignal.aba9157.
10
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.